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We report a case of erythrodermic psoriasis with bullous pemphigoid (BP) in a 68-year-old male. The patient had a
history of psoriasis for 35 years and tense, blisterlike lesions for 4 months. He presented with diffuse flushing, infiltrative
swelling, and tense blisterlike lesions on his head, trunk, and limbs. This patient was successfully treated by a
combination of methotrexate and compound glycyrrhizin. We also discuss the clinical manifestations, histopathological
features, and differentiation of erythrodermic psoriasis with BP and present a review of the pertinent literature.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1853737109114076
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Erythrodermic psoriasis is an uncommon, severe form of
psoriasis, accounting for about 1% of psoriatic patients.
BP predominantly affects older people, with clinical fea-
tures of tense bullae on trunk and limbs. By immunoblot
analysis, 200-kDa or 180-kDa antigen identified in dermal
extracts have been shown to play a major role in patients
with psoriasis and BP [1]. Anti-laminin-γ1 pemphigoid
(ALγ1P), a new kind of autoimmune BP, was detected as a
200-kDa pathogenic antigen in dermal extracts. Half the
ALγ1P cases were reported to be associated with psoriasis
[2]. Coexistence of erythrodermic psoriasis with BP is rare.
To the best of our knowledge, only two cases of such asso-
ciation have been described.
Here we report a case of a 68-year-old male who suf-
fered from erythrodermic psoriasis with BP who was suc-
cessfully treated with a combination of methotrexate and
compound glycyrrhizin.
Case presentation
A 68-year-old Chinese male complained of a history of
psoriasis for more than 30 years and tense, blisterlike* Correspondence: lwf888026@163.com
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unless otherwise stated.lesions for 4 months. He had been prescribed multiple
therapeutic measures, and after he was treated with narrow-
spectrum ultraviolet on October 17, 2012, the tense, blisterlike
lesions were noticed on the distal limbs, particularly the
feet. The patient was treated with prednisone 30 mg
daily, and his condition was gradually brought under
control, but suddenly worsened after a week of discontinu-
ing prednisone. He is an engineer who has had no history
of smoking, drinking, hypertension, or diabetes. Physical
examination showed diffuse flushing, infiltrative swelling,
tense transparent vesicles and blisters on his head, trunk,
and limbs. There was palmoplantar desquamation with
glove- and sock-like distribution. After peeling, the skin
was meager and bright red (Figure 1a). Bulla spread and
Nikolsky’s signs were negative. There was no evidence of
any cardiac, pulmonary, hepatic, nephritic, or central ner-
vous system involvement evidenced by electrocardiogram,
chest X-ray, abdominal ultrasound examination, or cranial
computed tomography.
Laboratory analysis revealed a white blood cell count
of 6.12 × 109/L (normal: 3.97–9.15 × 109/L) with 1.19 × 109/L
eosinophils (normal: 0.00–0.50 × 109/L); hemoglobin
122.0g/L (131–172 g/L). There was an elevated erythrocyte
sedimentation rate (ESR) of 18 mm/h (normal: 0–15 mm/h);
C-reactive protein (CRP) level was 28.1 mg/L (normal 0–3his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Topical rash before treatment and normal condition after treatment on his limbs and feet. (a) Diffuse flushing, tense, transparent
vesicles, and blisters on his limbs and feet. Skin lesions showing diffuse flushing, infiltrative swelling, a large number of branlike scales on his
limbs, and tense, transparent vesicles and blisters on his feet. (b) Diffuse flushing and infiltrative swelling has subsided. Skin lesions cleared and
normal condition restored.
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gC were positive in the peripheral blood serum.
Histopathological biopsy taken from the left forearm
showed hyperkeratosis, parakeratosis, Munro’s microabs-
cess, hypogranulosis, and acanthosis with regular rete
elongation, and congested and dilated blood vessels in
the superficial dermis (Figure 2a). There was subepider-
mal blistering with eosinophil-rich inflammatory infil-
trates at the bottom of the blister, which was typical for BP
(Figure 2b). Direct immunofluorescence revealed immuno-
globulin G (IgG) and C3 deposited along the basement
membrane (Figure 3a). Indirect immunofluorescence on
normal human skin showed that IgG was deposited on the
epidermal side (Figure 3b). Based on clinical and histo-
pathological features, a final diagnosis of erythrodermic
psoriasis with BP was made.
The patient was treated with methotrexate at a dose of
15 mg weekly and compound glycyrrhizin 150 mg daily.
After 2 weeks, the patient’s condition had improved,
and the diffuse flushing and the infiltrative swelling hadFigure 2 Characteristics of skin histopathology supporting the diagno
and dilated blood vessels in the superficial dermis. Skin biopsy showing hy
acanthosis with regular elongation of rete pegs, and congested and dilated
subepidermally. Subepidermal blister filled with serous exudate, with eosin
(H&E, ×100).subsided (Figure 1b). He was in clinical remission at 6
months’ follow-up. All hematological and biochemical ex-
aminations were normal and no new lesions were noticed.
Discussion
The pathogenesis of erythrodermic psoriasis with BP is
not fully understood, but much investigation has been
done on the pathogenetic association between psoriasis
and BP when treated with sartan drugs, including losartan-
induced BP in a psoriatic patient [3]. After receiving PUVA
or UVB therapy for psoriasis, many patients presented with
bullous lesions, so ultraviolet therapy was regarded as a
possible precipitating factor in triggering bullous lesions in
psoriatic patients. The mechanism was thought to be that
PUVA or UVB raised the immunogenecity of the basement
membrane proteins, leading to a higher risk of the auto-
antibody formation [4].
Certain clinical features are used to differentiate psoria-
sis with BP from other diseases. Seborrheic dermatitis
often affects the scalp, face, and torso. Typically, it affectsses of psoriasis and BP. (a) Munro’s microabscesses, hypogranulosis,
perkeratosis, parakeratosis, Munro’s microabscesses, hypogranulosis,
blood vessels in the superficial dermis (H&E, ×200). (b) Blister located
ophil-rich inflammatory infiltrates at the bottom of the blister
Figure 3 Immunofluorescence revealing histopathologic characteristics of bullous pemphigoid. (a) IgG and C3 deposited along the
basement membrane. Direct immunofluorescence revealing IgG and C3 deposited along the basement membrane (×100). (b) IgG deposited on
the epidermal side. Indirect immunofluorescence of normal human skin showing IgG deposited on the epidermal side (×200).
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and adults, it usually presents as scalp scaling similar to
dandruff or as mild to marked erythema of the nasolabial
fold [5]. Sometimes psoriatic lesions are similar to those
of chronic eczema. However, there are some telltale signs:
psoriasis tends to involve the elbows and knees, but ec-
zema favors the inside of the arms and back of the knees.
BP and epidermolysis bullosa acquisita have many com-
mon characteristics, such as proclivity for the elderly and
presence of tense and subepidermal blisters. But in our
patient, indirect immunofluorescence of BP on normal hu-
man skin showed IgG deposited on the epidermal side.
Circulating antibodies to BP180 NC16A and BP230-gC
were positive in the serum of peripheral blood [6]. By these
features, BP can be differentiated from epidermolysis bul-
losa acquisita.
Erythrodermic psoriasis and BP seldom coexist in the
same patient. To the best of our knowledge, only two
cases of such association have been described. One pa-
tient received cyclosporine therapy combined with sys-
temic steroids [7]. Another was successfully treated with a
combination of acitretin and azathioprine [8]. We treated
our patient with a combination of methotrexate and com-
pound glycyrrhizin.
Methotrexate has been shown to have a significant
therapeutic effect in the treatment of psoriasis [9]. A re-
cent retrospective review of 710 outpatients who used
methotrexate to treat moderate to severe psoriasis dem-
onstrated that methotrexate is relatively safe [10]. In the
past 10 years, compound glycyrrhizin used in the clinic
reduced the activity of the T-lymphocyte subset, helped
recover lymphocytes, and had satisfactory efficacy and
high safety in the treatment of psoriasis vulgaris. When-
ever we applied compound glycyrrhizin to treat a patient
suffering from recurrent cutaneous necrotizing eosino-
philic vasculitis, we got a good result [11]. With a com-
bination of methotrexate and compound glycyrrhizin,
we can quickly clear both erythrodermic psoriasis andBP lesions. Some studies have found that interleukin 8
(IL-8) plays an important role not only in inflammatory
acne vulgaris [12], but also in psoriasis and bullous pem-
phigoid [13,14], so compound glycyrrhizin might block
production of some cytokines, including IL-8, in the
treatment of erythrodermic psoriasis and bullous pem-
phigoid lesions. We received valuable experience from
the first case using this combined treatment, which en-
couraged us to continue these clinical trials for such
patients.
Conclusion
Erythrodermic psoriasis with BP has a low incidence of
coexisting in the same patient. We have shown that
methotrexate and compound glycyrrhizin can be an ef-
fective alternative therapy in the treatment of erythro-
dermic psoriasis with BP, but long-term prospective
studies of this regimen and an adequate sample size are
required to assure its safety and efficacy.
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